In a filing, West Pharmaceutical Services, Inc. revealed its Officer Green Eric Mark acquired Company’s shares for reported $9.36 million on Aug 06 ’24. In the deal valued at $304.71 per share,30,732 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Green Eric Mark sold 30,732 shares, generating $9,364,409 in total proceeds. Upon selling the shares at $304.71, the President, CEO and Board Chair now owns 161,898 shares.
Before that, Abraham Silji sold 1,800 shares. West Pharmaceutical Services, Inc. shares valued at $595,404 were divested by the SVP, Chief Technology Officer at a price of $330.78 per share. As a result of the transaction, Abraham Silji now holds 2,860 shares, worth roughly $0.84 million.
Jefferies upgraded its West Pharmaceutical Services, Inc. [WST] rating to a Buy from a a Hold in a research note published on February 07, 2024; the price target was increased to $536 from $323. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid June from “a Neutral” to “a Buy”. Stephens also remained covering WST and has increased its forecast on April 11, 2023 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Deutsche Bank started covering the stock on December 14, 2022. It rated WST as “a Hold”.
Price Performance Review of WST
On Tuesday, West Pharmaceutical Services, Inc. [NYSE:WST] saw its stock jump 1.67% to $295.42. Over the last five days, the stock has lost -2.97%. West Pharmaceutical Services, Inc. shares have fallen nearly -16.10% since the year began. Nevertheless, the stocks have fallen -25.16% over the past one year. While a 52-week high of $415.73 was reached on 02/07/24, a 52-week low of $265.00 was recorded on 07/25/24. SMA at 50 days reached $316.14, while 200 days put it at $349.75.
Levels Of Support And Resistance For WST Stock
The 24-hour chart illustrates a support level at 292.39, which if violated will result in even more drops to 289.35. On the upside, there is a resistance level at 297.20. A further resistance level may holdings at 298.97. The Relative Strength Index (RSI) on the 14-day chart is 43.21, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.01%. Stochastics%K at 49.22% indicates the stock is a holding.
How much short interest is there in West Pharmaceutical Services, Inc.?
A steep rise in short interest was recorded in West Pharmaceutical Services, Inc. stocks on
The most recent change occurred on November 30, 2022 when UBS began covering the stock and recommended ‘”a Neutral”‘ rating along with a $250 price target.
